Pacific Biosciences of California Inc (NAS:PACB)
$ 1.825 -0.215 (-10.54%) Market Cap: 497.37 Mil Enterprise Value: 972.47 Mil PE Ratio: 0 PB Ratio: 1.01 GF Score: 62/100

Pacific Biosciences of California Inc Investor Day Transcript

Nov 15, 2022 / 01:00PM GMT
Release Date Price: $11.2 (+10.56%)
Operator

Todd Friedman, Director, Investor Relations.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

All right. Good morning, everybody. Thank you for joining us at PacBio's first ever Investor Day. Thrilled to be here in person in New York City with you all, and welcome to everybody joining in remotely as well. I hope you all had a chance to look at our latest sequencers out in the foyer, Revio and Onso. If you haven't, they'll be here all day. So during a break or lunch, feel free to get a demo. So real quick, the agenda, packed day, we'll have our leadership talking through everything from our strategy, our innovation, our new products, the markets we serve and some financial information as well. And we'll have 2 Q&A sessions throughout the day. So plenty of time to ask questions. And at any point, feel free to use the QR code on your table to take a look at the agenda. And then real quick, flashing up our safe harbor forward-looking statement. We'll be making forward-looking statements. Please refer to our SEC filings for more information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot